COMPANY PROFILE

Oerth Bio

Explore full profile

Developing targeted protein degraders for agricultural applications

Durham, United StatesFounded 2019Food

Valuation $250–500M Last recorded · 2020

Headcount <100 Current team size

Total funding $50–100M Disclosed equity funding

Unlock exact values

About Oerth Bio

Oerth Bio is a startup operating in the agricultural biotechnology industry, aiming to revolutionize the global food system. The company's primary focus is on enhancing the resilience, durability, and quality of crops while minimizing the environmental impact of agriculture. They achieve this by harnessing a natural protein recycling system in plants, known as PROTAC® protein degraders. This technology unlocks new possibilities for crop protection and plant health, helping crops withstand abiotic stress and thrive despite pests and diseases.

Oerth Bio's business model is centered on the development and commercialization of this innovative biotechnology. They serve a broad range of clients, including farmers, agricultural businesses, and potentially even governments, who are all interested in sustainable and efficient crop production.

The company generates revenue by selling their PROTAC® protein degraders and related services. These products not only help increase crop yield but also contribute to a more sustainable and environmentally friendly agriculture industry.

Oerth Bio is led by a team of experts with significant experience in agricultural chemistry, biotechnology, and the pharmaceutical industry. This collective expertise positions the company well to navigate the complexities of the biotech market and drive innovation in sustainable agriculture.

MoreLess Source: Dealroom company data

At a glance

Status: Operational
Founded: 2019
Headquarters: Durham, United States
Employees: 13
Open positions: None listed
Dealroom signal: 28.6/100
Industry: Food
Sub-industry: AgriTech
Sector: Food, Biotechnology, Spinout
Business model: Manufacturing
Client focus: b2b
Links: Website LinkedIn X

Knowledge graph

Founder mafia, market maps, research and news connected to this company by Dealroom

Funding history

2 recorded events

Company financing events and reported valuations.

Deal type	Date	Amount	Valuation	Investors	Source
EARLY VCOther financing	Feb 2020	$55M	$220M	Arvinas	—
SPINOUTOther financing	Jan 2019	$0	—	Yale University	—

Showing the latest 2 of 2 recorded eventsBook a demo for the full funding history →

Growth signals

Oerth Bio website traffic

Latest recorded traffic for Oerth Bio is 1.1K monthly website visits, down 15.4% over the last three months. Oerth Bio's team declined 45.8% over the past year.

Latest monthly visits1.1K 3-month web change-15.4% 1-year team growth-45.8%

Monthly website visitsFeb 2020–Jan 2026

Explore monthly traffic historyTrack growth over time and compare with peersBook a demo

Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Company	Headquarters	Status	Employees	Total funding	Valuation
EIEclipse IngredientsInnovative plant-based ingredients enhancing taste and nutrition	Brisbane, Australia	Operational	13	$4.5M	$18M
ABAgteria BiotechMolecule feed additive reducing cattle methane emissions	Stockholms kommun, Sweden	Operational
NINitroVoltDeveloping a small-scale ammonia synthesis unit, to give farmers control over fertilizer production	Gladsaxe Municipality, Denmark	Operational
APAPEXzymesAPEXzymes develops high-performance microbial technologies for the industrial production of biofertilizers and enzymes applied to the biofuels and food sectors	Campinas, Brazil	Operational
PEPesteveneBiological crop protection that actually works	Riga, Latvia	Operational
EBElysia Creative BiologyMaking climate tech that's powered by agriculture	Raleigh, United States	Operational
MYMyco4FoodDeveloping a scalable bioreactor system for solid-state fermentation	Copenhagen, Denmark	Operational
SESea2CellDeveloping a sustainable cell-cultured fish using immortalized fish cell lines with improved proliferation rates	Qiryat Shemona, Israel	Operational